Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Reprogramming of astrocytes to neuronal-like cells in spinal cord injury: a systematic review

Abstract

Study design

A Systematic Review

Objectives

To determine the therapeutic efficacy of in vivo reprogramming of astrocytes into neuronal-like cells in animal models of spinal cord injury (SCI).

Methods

PRISMA 2020 guidelines were utilized, and search engines Medline, Web of Science, Scopus, and Embase until June 2023 were used. Studies that examined the effects of converting astrocytes into neuron-like cells with any vector in all animal models were included, while conversion from other cells except for spinal astrocytes, chemical mechanisms to provide SCI models, brain injury population, and conversion without in-vivo experience were excluded. The risk of bias was calculated independently.

Results

5302 manuscripts were initially identified and after eligibility assessment, 43 studies were included for full-text analysis. After final analysis, 13 manuscripts were included. All were graded as high-quality assessments. The transduction factors Sox2, Oct4, Klf4, fibroblast growth factor 4 (Fgf4) antibody, neurogenic differentiation 1 (Neurod1), zinc finger protein 521 (Zfp521), ginsenoside Rg1, and small molecules (LDN193189, CHIR99021, and DAPT) could effectively reprogramme astrocytes into neuron-like cells. The process was enhanced by p21-p53, or Notch signaling knockout, valproic acid, or chondroitin sulfate proteoglycan inhibitors. The type of mature neurons was both excitatory and inhibitory.

Conclusion

Astrocyte reprogramming to neuronal-like cells in an animal model after SCI appears promising. The molecular and functional improvements after astrocyte reprogramming were demonstrated in vivo, and further investigation is required in this field.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: PRISMA 2020 Flowchart for New Systematic Review.

Similar content being viewed by others

Data availability

All datasets for this study are available from the corresponding author upon reasonable request.

References

  1. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7–35. https://doi.org/10.1007/s00401-009-0619-8.

    Article  PubMed  Google Scholar 

  2. Yang T, Xing L, Yu W, Cai Y, Cui S, Chen G. Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury. FASEB J. 2020;34:15504–15. https://doi.org/10.1096/fj.202001657RR.

    Article  CAS  PubMed  Google Scholar 

  3. Huang X, Wang C, Zhou X, Wang J, Xia K, Yang B, et al. Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury. CNS Neurosci Ther. 2020;26:940–51. https://doi.org/10.1111/cns.13390.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Spinal cord injury n.d. https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury. Accessed 14 Jul 2023.

  5. Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci. 2006;7:628–43. https://doi.org/10.1038/nrn1955.

    Article  CAS  PubMed  Google Scholar 

  6. Su Z, Niu W, Liu ML, Zou Y, Zhang CL. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat Commun. 2014;5:3338. https://doi.org/10.1038/ncomms4338.

    Article  CAS  PubMed  Google Scholar 

  7. Youmans JR. Youmans & Winn neurological surgery. Eighth edition. Philadelphia, PA: Elsevier; 2023.

    Google Scholar 

  8. Chang J, Qian Z, Wang B, Cao J, Zhang S, Jiang F, et al. Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury. Cell Commun Signal. 2023;21:37. https://doi.org/10.1186/s12964-022-01036-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gao L, Peng Y, Xu W, He P, Li T, Lu X, et al. Progress in stem cell therapy for spinal cord injury. Stem Cells Int. 2020;2020:1–16. https://doi.org/10.1155/2020/2853650.

    Article  CAS  Google Scholar 

  10. Karami Fath M, Babakhaniyan K, Anjomrooz M, Jalalifar M, Alizadeh SD, Pourghasem Z, et al. Recent advances in glioma cancer treatment: conventional and epigenetic realms. Vaccines. 2022;10:1448. https://doi.org/10.3390/vaccines10091448.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen X, Li H. Neuronal reprogramming in treating spinal cord injury. Neural Regen Res. 2022;17:1440–5. https://doi.org/10.4103/1673-5374.330590.

    Article  CAS  PubMed  Google Scholar 

  12. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76. https://doi.org/10.1016/j.cell.2006.07.024.

    Article  CAS  PubMed  Google Scholar 

  13. Yang H, Liu CC, Wang CY, Zhang Q, An J, Zhang L, et al. Therapeutical strategies for spinal cord injury and a promising autologous astrocyte-based therapy using efficient reprogramming techniques. Mol Neurobiol. 2016;53:2826–42. https://doi.org/10.1007/s12035-015-9157-7.

    Article  CAS  PubMed  Google Scholar 

  14. Heinrich C, Blum R, Gascón S, Masserdotti G, Tripathi P, Sánchez R, et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol. 2010;8:e1000373. https://doi.org/10.1371/journal.pbio.1000373.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol. 2003;467:1–10. https://doi.org/10.1002/cne.10874.

    Article  CAS  PubMed  Google Scholar 

  17. Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 1999;23:257–71. https://doi.org/10.1016/s0896-6273(00)80778-3.

    Article  CAS  PubMed  Google Scholar 

  18. Zarei-Kheirabadi M, Hesaraki M, Kiani S, Baharvand H. In vivo conversion of rat astrocytes into neuronal cells through neural stem cells in injured spinal cord with a single zinc-finger transcription factor. Stem Cell Res Ther. 2019;10:380. https://doi.org/10.1186/s13287-019-1448-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tan Z, Qin S, Liu H, Huang X, Pu Y, He C, et al. Small molecules reprogram reactive astrocytes into neuronal cells in the injured adult spinal cord. J Adv Res. 2023:S2090123223001765. https://doi.org/10.1016/j.jare.2023.06.013.

  20. Yang R-Y, Chai R, Pan J-Y, Bao J-Y, Xia P-H, Wang Y-K, et al. Knockdown of polypyrimidine tract binding protein facilitates motor function recovery after spinal cord injury. Neural Regen Res. 2023;18:396. https://doi.org/10.4103/1673-5374.346463.

    Article  CAS  PubMed  Google Scholar 

  21. Scheff SW, Saucier DA, Cain ME. A statistical method for analyzing rating scale data: the BBB locomotor score. J Neurotrauma. 2002;19:1251–60. https://doi.org/10.1089/08977150260338038.

    Article  PubMed  Google Scholar 

  22. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006;23:635–59. https://doi.org/10.1089/neu.2006.23.635.

    Article  PubMed  Google Scholar 

  23. Hassannejad Z, Sharif-Alhoseini M, Shakouri-Motlagh A, Vahedi F, Zadegan SA, Mokhatab M, et al. Potential variables affecting the quality of animal studies regarding pathophysiology of traumatic spinal cord injuries. Spinal Cord. 2016;54:579–83. https://doi.org/10.1038/sc.2015.215.

    Article  CAS  PubMed  Google Scholar 

  24. Wang LL, Su Z, Tai W, Zou Y, Xu XM, Zhang CL. The p53 pathway controls SOX2-mediated reprogramming in the adult mouse spinal cord. Cell Rep. 2016;17:891–903. https://doi.org/10.1016/j.celrep.2016.09.038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Puls B, Ding Y, Zhang F, Pan M, Lei Z, Pei Z, et al. Regeneration of functional neurons after spinal cord injury via in situ NeuroD1-mediated astrocyte-to-neuron conversion. Front Cell Dev Biol. 2020;8:591883. https://doi.org/10.3389/fcell.2020.591883.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tan Z, Qin S, Yuan Y, Hu X, Huang X, Liu H, et al. NOTCH1 signaling regulates the latent neurogenic program in adult reactive astrocytes after spinal cord injury. Theranostics. 2022;12:4548–63. https://doi.org/10.7150/thno.71378.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen W, Zhang B, Xu S, Lin R, Wang W. Lentivirus carrying the NeuroD1 gene promotes the conversion from glial cells into neurons in a spinal cord injury model. Brain Res Bull. 2017;135:143–8. https://doi.org/10.1016/j.brainresbull.2017.10.001.

    Article  CAS  PubMed  Google Scholar 

  28. Kim J, Son Y, Hwang K, Park H, Kim Y, Kim M, et al. Synergistic enhancement of adeno‐associated virus‐mediated in vivo direct neuronal reprogramming by spatially aligned fibrous matrices in spinal cord injury models. Adv Therapeutics. 2023;6:2300040. https://doi.org/10.1002/adtp.202300040.

    Article  CAS  Google Scholar 

  29. Feng GD, He BR, Lu F, Liu LH, Zhang L, Chen B, et al. Fibroblast growth factor 4 is required but not sufficient for the astrocyte dedifferentiation. Mol Neurobiol. 2014;50:997–1012. https://doi.org/10.1007/s12035-014-8649-1.

    Article  CAS  PubMed  Google Scholar 

  30. Shen K, Wu D, Sun B, Zhu Y, Wang H, Zou W, et al. Ginsenoside Rg1 promotes astrocyte‐to‐neuron transdifferentiation in rat and its possible mechanism. CNS Neurosci Ther. 2023;29:256–69. https://doi.org/10.1111/cns.14000.

    Article  CAS  PubMed  Google Scholar 

  31. All AH, Al-Nashash H. Comparative analysis of functional assessment for contusion and transection models of spinal cord injury. Spinal Cord. 2021;59:1206–9. https://doi.org/10.1038/s41393-021-00698-2.

    Article  PubMed  Google Scholar 

  32. Guo Z, Zhang L, Wu Z, Chen Y, Wang F, Chen G. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model. Cell Stem Cell. 2014;14:188–202. https://doi.org/10.1016/j.stem.2013.12.001.

    Article  CAS  PubMed  Google Scholar 

  33. Roybon L, Mastracci TL, Ribeiro D, Sussel L, Brundin P, Li J-Y. GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2. Cereb Cortex. 2010;20:1234–44. https://doi.org/10.1093/cercor/bhp187.

    Article  PubMed  Google Scholar 

  34. Li T, Zhao X, Duan J, Cui S, Zhu K, Wan Y, et al. Targeted inhibition of STAT3 in neural stem cells promotes neuronal differentiation and functional recovery in rats with spinal cord injury. Exp Ther Med. 2021;22:711. https://doi.org/10.3892/etm.2021.10143.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Xu L, Tang Y-Y, Ben X-L, Cheng M-H, Guo W-X, Liu Y, et al. Ginsenoside Rg1-induced activation of astrocytes promotes functional recovery via the PI3K/Akt signaling pathway following spinal cord injury. Life Sci. 2020;252:117642. https://doi.org/10.1016/j.lfs.2020.117642.

    Article  CAS  PubMed  Google Scholar 

  36. Hu J, Qian H, Xue Y, Fu X-D. PTB/nPTB: master regulators of neuronal fate in mammals. Biophys Rep. 2018;4:204–14. https://doi.org/10.1007/s41048-018-0066-y.

    Article  CAS  PubMed  Google Scholar 

  37. Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, et al. Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Nature. 2020;582:550–6. https://doi.org/10.1038/s41586-020-2388-4.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 2008;26:795–7. https://doi.org/10.1038/nbt1418.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Feng B, Ng J-H, Heng J-CD, Ng H-H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell. 2009;4:301–12. https://doi.org/10.1016/j.stem.2009.03.005.

    Article  CAS  PubMed  Google Scholar 

  40. Yoon Y-E, Im BG, Kim J, Jang J-H. Multifunctional Self-Adhesive Fibrous Layered Matrix (FiLM) for tissue glues and therapeutic carriers. Biomacromolecules. 2017;18:127–40. https://doi.org/10.1021/acs.biomac.6b01413.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was Acknowledged and funded by the Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences [grant number is 99-2-93-49972].

Author information

Authors and Affiliations

Authors

Contributions

VRM conceived the presented idea and supervised the project. Z.G. revised the manuscript and communicated with team members and the corresponding author. SDA was responsible for writing the protocol and report, screening potentially eligible studies, extracting and analyzing data, interpreting results, assessing the risk of bias of included studies, creating tables and figures, discussing the results, and manuscript drafting. HM, GR, KM, MRJ and SS contributed to screening potentially eligible studies and extracting data. JH and SK were responsible for revising the manuscript and providing critical feedback. MSN analyzed and interpreted the data and results. ZE and RM conducted the database searches.

Corresponding author

Correspondence to Vafa Rahimi-Movaghar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The Ethics Committee of Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, approved the study, and the reference number is IR.TUMS.SINAHOSPITAL.REC.1399.114.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alizadeh, S.D., Jalalifar, MR., Ghodsi, Z. et al. Reprogramming of astrocytes to neuronal-like cells in spinal cord injury: a systematic review. Spinal Cord 62, 133–142 (2024). https://doi.org/10.1038/s41393-024-00969-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41393-024-00969-8

Search

Quick links